Breaking News Instant updates and real-time market news.

GILD

Gilead

$66.50

0.22 (0.33%)

10:05
04/21/17
04/21
10:05
04/21/17
10:05

Piper Jaffray 'encouraged' by Gilead ACC inhibitor data in NASH

Piper Jaffray analyst Joshua Schimmer said Gilead's GS-0976 program in the treatment of NASH are the company's "most interesting" and the just announced data for the ACC inhibitor in a 10 patient study are very encouraging. The analyst, who continues to believe that reducing lipids is a key component for treating NASH, added that long term safety for inhibition of ACC will be necessary before he can have confidence in the program's potential. He keeps an Overweight rating on Gilead shares.

  • 22

    Apr

  • 02

    May

GILD Gilead
$66.50

0.22 (0.33%)

03/06/17
FBCO
03/06/17
NO CHANGE
FBCO
Near-Term acquisition of Bristol-Myers unlikely, says Credit Suisse
Credit Suisse analyst Vamil Divan says there is increasing investor focus on strategic actions and opportunities around Bristol-Myers (BMY) following the company's recent stumbles and the increased stake activist investors have taken in the stock. The analyst notes that "the big question" remains whether any of its peers may be interested in an outright acquisition, with Pfizer (PFE), Novartis (NVS) and Gilead (GILD) among the possible acquirers. While the numbers may make sense, Divan sees an acquisition in the next 9-12 months as unlikely as he needs more clarity on some of the large unknowns in the lung cancer market and macro issues such as corporate tax reform.
03/09/17
UBSW
03/09/17
DOWNGRADE
Target $72
UBSW
Neutral
Gilead transferred with a Neutral from Buy at UBS
UBS downgraded Gilead Sciences to Neutral after transferring coverage to Carter Gould. The company's hepatitis C sales have declined steadily since 2015 on decreased patient volume and pricing pressure, Gould told investors last night in a research note. The analyst believes Gilead's HCV sales need to stabilize before the stock moves higher. He cut his firm's price target for the shares to $72 from $118.
03/13/17
FBCO
03/13/17
NO CHANGE
Target $174
FBCO
Outperform
Incyte price target raised to $174 from $136 at Credit Suisse
Credit Suisse analyst Kennen MacKay raised his price target for Incyte (INCY) to $174 upon shifting to an M&A discounted cash flow net present value methodology. Incyte rallied late in the day on Friday amid speculation of a takeover by Gilead Sciences (GILD). Incyte could provide an attractive entry into immuno-oncology for an acquirer, MacKay tells investors in a research note. The company's epacadostat could be a "scarce immuno-oncology backbone blockbuster," the analyst contends. He anticipates "significant interest" in Incyte for this reason. MacKay keeps an Outperform rating on the shares.
03/20/17
JEFF
03/20/17
NO CHANGE
JEFF
Buy
Jefferies uncovers 'unnoticed' positive NASH data coming from Gilead
Jefferies analyst Brian Abrahams said his review of titles for the upcoming EASL meeting of the International Liver Congress appears to indicate that Gilead's ACC inhibitor GS-0976, which he calls "one of [the company's] least-talked-about assets in NASH," demonstrated significant positive effects in an as-yet-unreported phase 2 study. The analyst, who calls the presentation "unnoticed" and "not broadly discussed," believes the study may meaningfully de-risk a second NASH asset and could set the stage for increasing enthusiasm around Gilead's NASH program over the next 12 months. Abrahams keeps a Buy rating on Gilead shares. The ILC meeting is being held from April 19 to 23 in Amsterdam.

TODAY'S FREE FLY STORIES

08:40
06/29/17
06/29
08:40
06/29/17
08:40
General news
U.S. initial jobless claims rose 2k to 244k in the week ended June 24 »

U.S. initial jobless…

AMRN

Amarin

$3.78

0.29 (8.31%)

08:39
06/29/17
06/29
08:39
06/29/17
08:39
Recommendations
Amarin analyst commentary  »

Jefferies boosts Amarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$32.81

0.65 (2.02%)

08:39
06/29/17
06/29
08:39
06/29/17
08:39
Hot Stocks
Celltrion, Teva announce FDA acceptance of BLA for Rituxan biosimilar »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

IMNP

Immune Pharmaceuticals

$2.97

0.15 (5.32%)

08:38
06/29/17
06/29
08:38
06/29/17
08:38
Hot Stocks
Immune Pharmaceuticals reaches agreement on Pint Pharma transaction »

Immune…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKBA

Akebia

$15.50

-0.19 (-1.21%)

08:38
06/29/17
06/29
08:38
06/29/17
08:38
Technical Analysis
Technical View: Akebia falls on 4M share Spot Secondary »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

PIR

Pier 1 Imports

$5.38

0.04 (0.75%)

08:38
06/29/17
06/29
08:38
06/29/17
08:38
Downgrade
Pier 1 Imports rating change  »

Pier 1 Imports downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTLS

Chart Industries

$33.15

0.91 (2.82%)

08:37
06/29/17
06/29
08:37
06/29/17
08:37
Upgrade
Chart Industries rating change  »

Chart Industries upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$76.51

0.5 (0.66%)

, AMZN

Amazon.com

$990.33

13.55 (1.39%)

08:37
06/29/17
06/29
08:37
06/29/17
08:37
Periodicals
Walmart sending 'veiled' threats to truckers amid war with Amazon, NY Post says »

Walmart (WMT) is sending…

WMT

Wal-Mart

$76.51

0.5 (0.66%)

AMZN

Amazon.com

$990.33

13.55 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNI

Silver Spring

$11.28

0.1 (0.89%)

08:36
06/29/17
06/29
08:36
06/29/17
08:36
Hot Stocks
Silver Spring selected for Grant PUD advanced metering program »

Silver Spring Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPNC

Spectranetics

$38.35

7.95 (26.15%)

08:36
06/29/17
06/29
08:36
06/29/17
08:36
Downgrade
Spectranetics rating change  »

Spectranetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNA

Arena Pharmaceuticals

$16.53

1.3 (8.54%)

08:35
06/29/17
06/29
08:35
06/29/17
08:35
Hot Stocks
Arena Pharmaceuticals completes ralinepag Phase 1 trial »

Arena Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

CCJ

Cameco

$9.53

0.1056 (1.12%)

08:35
06/29/17
06/29
08:35
06/29/17
08:35
Initiation
Cameco initiated  »

Cameco initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBN

Commerce Union Bancshares

$26.04

1.54 (6.29%)

08:34
06/29/17
06/29
08:34
06/29/17
08:34
Hot Stocks
Commerce Union Bancshares raises quarterly dividend 9.1% to 6c per share »

Commerce Union Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

PFE

Pfizer

$33.75

-0.02 (-0.06%)

08:33
06/29/17
06/29
08:33
06/29/17
08:33
Hot Stocks
Pfizer to evaluate Alcyone's Pulsar technology to develop genetic therapy method »

Pfizer has entered into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

  • 02

    Aug

  • 27

    Aug

08:32
06/29/17
06/29
08:32
06/29/17
08:32
General news
Jobless Claims data reported »

Week of 6/24 Jobless…

08:32
06/29/17
06/29
08:32
06/29/17
08:32
General news
Real GDP data reported »

Real GDP up 1.4% vs.…

INPX

Inpixon

08:32
06/29/17
06/29
08:32
06/29/17
08:32
Syndicate
Inpixon raises $6M in a public offering of common stock and warrants »

Inpixon announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OA

Orbital ATK

$98.71

1.7 (1.75%)

08:32
06/29/17
06/29
08:32
06/29/17
08:32
Hot Stocks
Orbital ARK receives contract to repair trainer aircraft for Iraqi Air Force »

Orbital ATK has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CST

CST Brands

, LBIO

Lion Biotechnologies

08:30
06/29/17
06/29
08:30
06/29/17
08:30
Options
One new option listing and two option delistings on June 29th »

New option listings for…

CST

CST Brands

LBIO

Lion Biotechnologies

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$154.30

0.58 (0.38%)

08:26
06/29/17
06/29
08:26
06/29/17
08:26
Recommendations
McDonald's analyst commentary  »

McDonald's price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$27.08

-0.13 (-0.48%)

08:22
06/29/17
06/29
08:22
06/29/17
08:22
Upgrade
General Electric rating change  »

General Electric upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

$DJT

DJ Transportation Average

08:21
06/29/17
06/29
08:21
06/29/17
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:20
06/29/17
06/29
08:20
06/29/17
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:20
06/29/17
06/29
08:20
06/29/17
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.35

1.05 (3.85%)

08:20
06/29/17
06/29
08:20
06/29/17
08:20
Recommendations
Trinity Industries analyst commentary  »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.